Poder Preditivo dos Aspectos Demográficos e Clinicopatológicos de Pacientes com Melanoma Acral: uma Série de 394 Casos em um Único Centro no Brasil

Autores

DOI:

https://doi.org/10.32635/2176-9745.RBC.2023v69n4.4412

Palavras-chave:

melanoma, síndrome mão-pé, sobrevida, prognóstico

Resumo

Introdução: O melanoma acral (MA) está associado à alta mortalidade e à baixa sobrevida, e seu prognóstico é pior em comparação com os outros subtipos de melanoma. Objetivo: Analisar o poder preditivo de aspectos demográficos e clinicopatológicos em pacientes com MA. Método: Estudo retrospectivo com pacientes diagnosticados com MA entre janeiro de 2001 e dezembro de 2015. Foram coletadas características demográficas e clinicopatológicas. O desfecho foi a sobrevida global (SG) em cinco anos. Foram utilizados curvas de Kaplan-Meier, teste de log-rank e análise de regressão de Cox. Resultados: Foram identificados 394 pacientes com MA. A taxa de sobrevida em cinco anos para pacientes com MA foi de 45,6%. Os fatores preditivos da SG incluíram espessura de Breslow [hazard ratio (HR): 1,02, intervalo de confiança (IC) de 95%: 1,01-1,03], ulceração (HR: 4,06, IC 95%: 2,18-7,57) e invasão linfovascular (ILV) (HR: 2,12, IC 95%: 1,12-4,00). Conclusão: Tais achados destacam o prognóstico desfavorável do MA e o poder preditivo da espessura de Breslow, ulceração e ILV.

Downloads

Não há dados estatísticos.

Referências

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7-34. DOI: https://doi.org/10.3322/caac.21551

Reed RJ. New concepts in surgical pathology of the skin. In: Hartmann W, Kay S, Reed RJ, editors. Histopatogy. New York: John Wiley & Sons; 1976.

Bradford PT, Goldstein AM, McMaster ML, et al. Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005. Arch Dermatol. 2009;145(4):427-34. DOI: https://doi.org/10.1001/archdermatol.2008.609

Bristow I, Bower C. Melanoma of the foot. Clin Podiatr Med Surg. 2016;33(3):409-22. DOI: https://doi.org/10.1016/j.cpm.2016.02.008

Markovic SN, Erickson LA, Rao RD, et al. Malignant melanoma in the 21st century, part 2: staging, prognosis, and treatment. Mayo Clin Proc. 2007;82(4):490-513. DOI: https://doi.org/10.4065/82.4.490

Piliang MP. Acral lentiginous melanoma. Clin Lab Med. 2011;31(2):281-8. DOI: https://doi.org/10.1016/j.cll.2011.03.005

Green A, McCredie M, MacKie R, et al. A case-control study of melanomas of the soles and palms (Australia and Scotland). Cancer Causes Control. 1999;10(1):21-5. DOI: https://doi.org/10.1023/A:1008872014889

Phan A, Touzet S, Dalle S, et al. Acral lentiginous melanoma: histopathological prognostic features of 121 cases. Br J Dermatol. 2007;157(2):311-8. DOI: https://doi.org/10.1111/j.1365-2133.2007.08031.x

Rolón PA, Kramárová E, Rolón HI, et al. Plantar melanoma: a case-control study in Paraguay. Cancer Causes Control. 1997;8(6):850-6. DOI: https://doi.org/10.1023/A:1018460227927

Kuchelmeister C, Schaumburg-Lever G, Garbe C. Acral cutaneous melanoma in caucasians: clinical features, histopathology and prognosis in 112 patients. Br J Dermatol. 2000;143(2):275-80. DOI: https://doi.org/10.1046/j.1365-2133.2000.03651.x

Pollack LA, Li J, Berkowitz Z, et al. Melanoma survival in the United States, 1992 to 2005. J Am Acad Dermatol. 2011;65(5 Supl 1):S78-86. DOI: https://doi.org/10.1016/j.jaad.2011.05.030

Slingluff CL, Vollmer R, Seigler HF. Acral melanoma: a review of 185 patients with identification of prognostic variables. J Surg Oncol. 1990;45(2):91-8. DOI: https://doi.org/10.1002/jso.2930450207

Nunes LF, Quintella Mendes GL, Koifman RJ. Acral melanoma: a retrospective cohort from the Brazilian National Cancer Institute (INCA). Melanoma Res. 2018;28(5):458-64. DOI: https://doi.org/10.1097/CMR.0000000000000476

O’Leary JA, Berend KR, Johnson JL, et al. Subungual melanoma. A review of 93 cases with identification of prognostic variables. Clin Orthop Relat Res. 2000;(378):206-12. DOI: https://doi.org/10.1097/00003086-200009000-00031

Fitzpatrick TB. Enigma of the pathogenesis of primary melanoma: changing incidence and mortality in Japan and the United States. J Invest Dermatol. 1989;92(5 Supl):234S-5S. DOI: https://doi.org/10.1111/1523-1747.ep13075615

Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg. 1970;172(5):902-8. DOI: https://doi.org/10.1097/00000658-197011000-00017

Clark WH, From L, Bernardino EA, et al. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res. 1969;29(3):705-27.

Gershenwald JE, Scolyer RA. Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond. Ann Surg Oncol. 2018;25(8):2105-10. DOI: https://doi.org/10.1245/s10434-018-6513-7

Gershenwald JE, Scolyer RA, Hess KR, et al. Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(6):472-92. DOI: https://doi.org/10.3322/caac.21409

Conselho Nacional de Saúde (BR). Resolução n° 466, de 12 de dezembro de 2012. Aprova as diretrizes e normas regulamentadoras de pesquisas envolvendo seres humanos. Diário Oficial da União, Brasília, DF. 2013 jun 13; Seção I:59.

Bello DM, Chou JF, Panageas KS, et al. Prognosis of acral melanoma: a series of 281 patients. Ann Surg Oncol. 2013;20(11):3618-25. DOI: https://doi.org/10.1245/s10434-013-3089-0

Cascinelli N, Zurrida S, Galimberti V, et al. Acral lentiginous melanoma. A histological type without prognostic significance. J Dermatol Surg Oncol. 1994;20(12):817-22. DOI: https://doi.org/10.1111/j.1524-4725.1994.tb03711.x

Fortin PT, Freiberg AA, Rees R, et al. Malignant melanoma of the foot and ankle. J Bone Joint Surg Am. 1995;77(9):1396-403. DOI: https://doi.org/10.2106/00004623-199509000-00016

Scrivner D, Oxenhandler RW, Lopez M, et al. Plantar lentiginous melanoma. A clinicopathologic study. Cancer. 1987;60(10):2502-9. DOI: https://doi.org/10.1002/1097-0142(19871115)60:10<2502::AID-CNCR2820601026>3.0.CO;2-V

Collins KK, Fields RC, Baptiste D, et al. Racial differences in survival after surgical treatment for melanoma. Ann Surg Oncol. 2011;18(10):2925-36. DOI: https://doi.org/10.1245/s10434-011-1706-3

Krementz ET, Feed RJ, Coleman WP, et al. Acral lentiginous melanoma. a clinicopathologic entity. Ann Surg. 1982;195(5):632-45. DOI: https://doi.org/10.1097/00000658-198205000-00013

Finley RK, Driscoll DL, Blumenson LE, et al. Subungual melanoma: an eighteen-year review. Surgery. 1994;116(1):96-100.

Kato T, Suetake T, Tabata N, et al. Epidemiology and prognosis of plantar melanoma in 62 japanese patients over a 28-year period. Int J Dermatol. 1999;38(7):515-9. DOI: https://doi.org/10.1046/j.1365-4362.1999.00736.x

Lv J, Dai B, Kong Y, et al. Acral Melanoma in Chinese: a clinicopathological and prognostic study of 142 cases. Sci Rep. 2016;6:31432. DOI: https://doi.org/10.1038/srep31432

Seiji M, Takematsu H, Hosokawa M, et al. Acral melanoma in Japan. J Invest Dermatol. 1983;80(Supl):56s-60s. DOI: https://doi.org/10.1111/1523-1747.ep12537212

Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27(36):6199-206. DOI: https://doi.org/10.1200/JCO.2009.23.4799

Crompton JG, Gilbert E, Brady MS. Clinical implications of the eighth edition of the American Joint Committee on Cancer melanoma staging. J Surg Oncol. 2019;119(2):168-74. DOI: https://doi.org/10.1002/jso.25343

Gershenwald JE, Ross MI. Sentinel-lymph-node biopsy for cutaneous melanoma. N Engl J Med. 2011;364(18):1738-45. DOI: https://doi.org/10.1056/NEJMct1002967

Maduekwe UN, Hornicek FJ, Springfield DS, et al. Role of sentinel lymph node biopsy in the staging of synovial, epithelioid, and clear cell sarcomas. Annals of Surgical Oncology. 2009;16(5):1356-63. DOI: https://doi.org/10.1245/s10434-009-0393-9

Morton DL, Thompson JF, Cochran AJ, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med. 2014;370(7):599-609. DOI: https://doi.org/10.1056/NEJMoa1310460

Egger ME, Gilbert JE, Burton AL, et al. Lymphovascular invasion as a prognostic factor in melanoma. Am Surg. 2011;77(8):992-7. DOI: https://doi.org/10.1177/000313481107700816

Publicado

2024-01-10

Como Citar

1.
Nunes LF, Oliveira LC, Mendes GLQ, Wainstain AJA, Thuler LCS, Bergmann A. Poder Preditivo dos Aspectos Demográficos e Clinicopatológicos de Pacientes com Melanoma Acral: uma Série de 394 Casos em um Único Centro no Brasil. Rev. Bras. Cancerol. [Internet]. 10º de janeiro de 2024 [citado 29º de abril de 2024];69(4):e-234412. Disponível em: https://rbc.inca.gov.br/index.php/revista/article/view/4412

Edição

Seção

ARTIGO ORIGINAL

Artigos mais lidos pelo mesmo(s) autor(es)

1 2 3 4 > >>